Doneparthi, P.S.; Cao, H.; Chen, W.; Dou, W.; Fang, H.-B.; Smith, J.P.
Mechanistic Insights into Proglumide’s Role in Immune Cell Efficacy and Response to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma. Cancers 2025, 17, 2998.
https://doi.org/10.3390/cancers17182998
AMA Style
Doneparthi PS, Cao H, Chen W, Dou W, Fang H-B, Smith JP.
Mechanistic Insights into Proglumide’s Role in Immune Cell Efficacy and Response to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma. Cancers. 2025; 17(18):2998.
https://doi.org/10.3390/cancers17182998
Chicago/Turabian Style
Doneparthi, Priyanka S., Hong Cao, Wenqiang Chen, Wenyu Dou, Hong-Bin Fang, and Jill. P. Smith.
2025. "Mechanistic Insights into Proglumide’s Role in Immune Cell Efficacy and Response to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma" Cancers 17, no. 18: 2998.
https://doi.org/10.3390/cancers17182998
APA Style
Doneparthi, P. S., Cao, H., Chen, W., Dou, W., Fang, H.-B., & Smith, J. P.
(2025). Mechanistic Insights into Proglumide’s Role in Immune Cell Efficacy and Response to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma. Cancers, 17(18), 2998.
https://doi.org/10.3390/cancers17182998